Covid research helped Swiss response, says Science Foundation
The National Science Foundation says it has funded important Covid-19 research in Switzerland which also helped the government to adapt its recommendations.
Keystone / Michael Buholzer
The National Science Foundation's CHF45 million ($45.8 million) support to Covid-19 research in Switzerland has made an important contribution to tackling the pandemic so far, it saidExternal link on Tuesday.
This content was published on
2 minutes
RTS/jc
Despite high pressure and sometimes difficult working conditions, researchers have presented impressive results, said epidemiologist Marcel Salathé of the Federal Technology Institute Lausanne (EPFL) who chairs the steering committee of the National Research Programme “Covid-19”. This programme includes 200 researchers involved in 28 projects with a total of CHF20 million.
In the early phase of the pandemic, epidemiological and monitoring projects provided important findings on the transmissibility of the virus, mobility patterns of the population during the partial lockdown, and degree of acceptance of restrictions, which allowed the Swiss government to adapt its recommendations, says the Science Foundation.
Another early milestone was the development of an inexpensive mass test by EPFL researchers which made it possible for the first time to detect Covid-19-specific antibodies in broad population groups, including in kindergartens.
It says EAWAGExternal link wastewater monitoring, which measures the concentration of Covid-19 viruses in water bodies, was a “resounding success” and has now been extended to over a hundred sites.
Important findings in the biomedical field include effects of the virus on children, on the mental and cognitive health of adults, and recognition of Long Covid as a health problem that is still not sufficiently understood, according to the press release.
Results from tests on Covid-19 patients of drugs originally developed for other diseases were more mixed. Although there were some “successful approaches”, some studies were also discontinued “as the strategies pursued proved ineffective”, says the science foundation.
Ongoing research includes the development of new vaccines and a nasal spray vaccine for Covid-19.
Popular Stories
More
Life & Aging
Zurich: how the world capital of housing shortages is tackling the problem
In Switzerland more people are being referred to electrical therapies or psychedelic-assisted psychotherapy. Are there similar approaches where you live?
Is your place of origin, your Heimatort, important to you?
Every Swiss citizen has a Heimatort, a place of origin, but many have never visited theirs. What’s your relationship with your Heimatort? What does it mean to you?
Swiss companies urged to improve accident prevention
This content was published on
To mark World Day for Safety and Health at Work on Monday, Suva is calling on companies to strengthen their prevention culture. Nearly 3 million people worldwide die every year in the course of their work.
Francesca Torrani voted Swiss Journalist of the Year
This content was published on
Francesca Torrani has been voted Swiss Journalist of the Year for her radio reports on the people in canton Ticino and their lives.
This content was published on
Traffic jams stretching for kilometres continued to build up in front of the two portals of the Gotthard road tunnel in Switzerland on Sunday.
Swiss and German virologists raise hopes of nasal coronavirus vaccine
This content was published on
Swiss and German virologists working on a nasal vaccine for Covid-19 say such a technique could be much more effective against the virus.
Swiss researchers discover antibody signature that could predict Long Covid
This content was published on
Immunologists in Zurich found lower levels of two types of immunoglobulins in patients who developed post-acute Covid-19 syndrome.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.